Apremilast for Oral Mucosal‐Predominant Resistant Pemphigus Vulgaris: A Promising Adjunctive Treatment
The authors declare no conflicts of interest. The raw data supporting the conclusions of this article will be made available by the corresponding authors. Figure S1: odi70134-sup-0001-TableS1.docx. Table S1: odi70134-sup-0002-FigureS1.docx. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
Authors
- Hongyan Ji (ORCID: https://orcid.org/0000-0002-6388-8049)
- Bintao Su
- Quanhong Zhang (ORCID: https://orcid.org/0009-0004-3796-0395)
- Zhi Liu
- Jinbo Chen (ORCID: https://orcid.org/0000-0002-9665-8506)
- Liuqing Chen (ORCID: https://orcid.org/0000-0002-8398-4652)
- Li Wan (ORCID: https://orcid.org/0000-0003-4434-9426)
- Lang Yu
Institutions
- University of North Carolina at Chapel Hill (US)
- Jianghan University (CN)
- Wuhan No.1 Hospital (CN)
- Wuhan No. 7 Hospital (CN)
- Wuhan No.9 Hospital (CN)
- Huazhong University of Science and Technology (CN)
- Southern Medical University (CN)
Publication Details
- Journal
- Oral Diseases
- Published
- 2025-11-02
- DOI
- https://doi.org/10.1111/odi.70134
- Citations
- 1
- Primary Topic
- Autoimmune Bullous Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 1.47